SmartTRAK Life Sciences News and Analysis Blog in the Orthopedics, Wound, and Neuro Therapies Market Segments
.png)
Cerapedics’ CEO Valeska Schroeder discusses the company’s newly PMA-approved PearlMatrix P-15 Peptide En...
James Voos, MD, chair of the Department of Orthopedics and Sports Medicine at University Hospitals Cleve...
SmartTRAK's industry experts discuss CMS’ proposed changes to skin substitutes reimbursement and their p...
Nicolas Piuzzi, MD, discusses the upcoming 2025 Robotic Orthopedic Concepts and Knowledge Symposium (ROC...
Stewart Strong, Q’Apel Medical’s recently appointed CEO, discusses the company, his priorities and plans...
SmartTRAK reviews CMS’ new WISeR model and its potential impact on the US Skin Substitutes Market. A new...
NASS Executive Director and CEO Eric Muehlbauer discusses NASS’s new Innovation NetWORK Summit in an int...
SmartTRAK is excited to attend the Society of Neurointerventional Surgery’s (SNIS) 22nd Annual Meeting &...
Spinal Simplicity’s Chief Strategy Officer Neil P. Dougherty shares how the company is advancing minimal...
SmartTRAK provides insights into the latest trends, research and consensus opinions in surgical Orthobio...
Login